Target intelligence / Profile preview

RNA, U6 small nuclear 248, pseudogene (RNU6-248P)

Target
RNU6-248P
Molecular classification
Pseudogene, Non-coding RNA pseudogene, Processed pseudogene
01

Overview

RNA, U6 small nuclear 248, pseudogene (RNU6-248P) is a **human genomic pseudogene** corresponding to the U6 small nuclear RNA gene family. U6 snRNA genes encode core components of the spliceosome, but RNU6-248P itself is classified as a **processed pseudogene**—a non-functional genomic locus thought to have arisen from duplication or retrotransposition events, lacking the capacity to encode a functional mature U6 RNA[1][5][9]. While classic pseudogenes are “dead” and nonfunctional, emerging evidence suggests some can be transcribed and exert regulatory effects as non-coding RNAs, for example by acting as competitive endogenous RNAs (ceRNAs) or providing microRNA-binding sites that modulate gene expression[4][8][2]. There is **no direct evidence** that RNU6-248P is expressed or functional, nor is it considered a druggable or therapeutic target. It is primarily annotated as a **genomic feature with no known protein, direct biological activity, or clinical application**[1][9][5].

Other names
RNU6-248P
02

Biological functions

Likely no direct biological function (in the protein-coding or classic RNA sense)Possible regulatory roles as non-coding RNA (inferred from pseudogene research[4][8][2])
03

Disease associations

Other (Potential role as a genomic marker; pseudogenes may be dysregulated in cancer, but there is no direct evidence for RNU6-248P itself[4][2][10])

Beyond the preview

Go deeper on RNA, U6 small nuclear 248, pseudogene (RNU6-248P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 248, pseudogene (RNU6-248P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call